Loading...

DiaSorin S.p.A.

DSRLFPNK
Healthcare
Medical - Diagnostics & Research
$107.68
$0.00(0.00%)

DiaSorin S.p.A. (DSRLF) Stock Overview

Explore DiaSorin S.p.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.6/100

Key Financials

Market Cap5.9B
P/E Ratio25.98
EPS (TTM)$4.04
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Week$104.69
1 Month$98.30
3 Months$113.85
1 Year Target$101.30

DSRLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DiaSorin S.p.A. (DSRLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $101.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.98 and a market capitalization of 5.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;